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Abstract GPCRs regulate all aspects of human physiology, and biophysical studies have
deepened our understanding of GPCR conformational regulation by different ligands. Yet there is
no experimental evidence for how sidechain dynamics control allosteric transitions between GPCR
conformations. To address this deficit, we generated samples of a wild-type GPCR (A2AR) that are
deuterated apart from 1H/13C NMR probes at isoleucine d1 methyl groups, which facilitated 1H/13C
methyl TROSY NMR measurements with opposing ligands. Our data indicate that low [Na+] is
required to allow large agonist-induced structural changes in A2AR, and that patterns of sidechain
dynamics substantially differ between agonist (NECA) and inverse agonist (ZM241385) bound
receptors, with the inverse agonist suppressing fast ps-ns timescale motions at the G protein
binding site. Our approach to GPCR NMR creates a framework for exploring how different regions




Our understanding of the molecular underpinnings of GPCR function has been greatly advanced
over the past two decades through a combination of X-ray crystal structures, computational simula-
tions, and spectroscopic studies of protein dynamics. Crystals of bovine rhodopsin provided the first
high-resolution picture of a GPCR’s architecture (Palczewski et al., 2000; Li et al., 2004), and struc-
tures of photoactivation intermediates (Nakamichi and Okada, 2006; Salom et al., 2006) and reti-
nal-free opsin (Park et al., 2008; Scheerer et al., 2008) further documented the structural
transitions involved in rhodopsin activation. For GPCRs activated by diffusible ligands, crystal struc-
tures of the human b2 adrenergic receptor (b2AR) with inverse agonists (Rosenbaum et al., 2007;
Cherezov et al., 2007), agonists (Rosenbaum et al., 2011; Rasmussen et al., 2011a; Warne et al.,
2011), and bound G protein (Rasmussen et al., 2011b) provided a molecular basis for understand-
ing how diffusible agonist binding can promote structural changes in a receptor to enhance
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signaling. Subsequent crystal structures have revealed the ligand binding pockets for GPCRs of
diverse function, responding to biogenic amines, purines, lipids, peptides, and proteins. While the
sequences of these GPCRs and their orthosteric ligand binding pockets are highly diverse, the over-
all structures are remarkably similar, with Ca rmsd values between unrelated receptors in the 2–3 Å
range. How these diverse ligands activate signaling by a small number of G proteins and arrestins
through a common structural scaffold remains a central problem for the GPCR field. Contributing to
this problem is the fact that most of the existing X-ray GPCR structures are of antagonist-bound
receptors locked in inactive conformations. For the few GPCRs that have been captured in both inac-
tive and active conformations, common structural changes include inward movements of
transmembrane (TM) helices at the orthosteric pocket, rearrangements of common core residues
through the helical bundle, and rigid-body outward movements of TM6 at the cytoplasmic surface
to expose G protein binding epitopes (Katritch et al., 2013).
Beyond the static pictures of GPCR conformations seen in these crystal structures, experimental
evidence for complex dynamic behavior has emerged from spectroscopic studies on purified recep-
tors. Unlike rhodopsin, which exhibits an efficient and ordered photon-induced transition from the
dark state conformation to metarhodopsin II (Choe et al., 2011a; Choe et al., 2011b), ligand-acti-
vated GPCRs generally show considerable basal activity that is reduced by inverse agonists. 19F
NMR and EPR experiments on the b2AR (Liu et al., 2012a; Manglik et al., 2015) and
eLife digest Almost every aspect of the human body – from our senses to our moods –
depends, in one way or another, on a large family of proteins called G-protein-coupled receptors.
These receptor proteins, known as GPCRs for short, detect signals from outside the cell and trigger
activity within the cell. This allows cells to gather information from their surroundings and to
communicate with each other. Importantly, since GPCRs regulate many processes in the body that
are involved in disease, it is perhaps unsurprising that over a third of all approved drugs target these
receptors.
Like all proteins, GPCRs are long chain-like molecules with a repetitive backbone and short
branches called sidechains. Each sidechain has its own chemical properties and electrical charge,
which can affect how different parts of the chain interact with each other and what shape the protein
can adopt. This in turn can influence how strongly a drug or other molecule can bind to a receptor
protein.
Protein crystallography is one technique that has been used to better understand how the
different GPCRs are built and how they work. The technique involves growing crystals from pure
samples of the protein; this locks millions of copies of the protein in place and provides a snapshot
of its shape. However, GPCRs – and especially their sidechains – are flexible and can adopt different
shapes, which cannot be seen fully by only looking at protein crystals.
Now, Clark, Dikiy et al. used another technique called nuclear magnetic resonance spectroscopy,
or NMR for short, to understand how drugs affect the fast moving sidechains within a GPCR. First,
genetically modified yeast was used to create samples of a GPCR called the adenosine receptor A2A
that were labelled with specific markers which made it easier to measure the structure and flexibility
of the protein by NMR.
This approach revealed that too much sodium in the sample’s solution supresses the large
structural changes that occur in the A2A receptor when it binds to a drug. Moreover, it showed that
the sidechains of several regions on the receptor move in different ways depending on whether the
receptor binds to an activating drug or an inhibiting drug.
These findings lay the groundwork for understanding how the movements of sidechains help to
activate or inhibit GPCRs, and will complement on-going studies using protein crystals. Moreover,
the new approach to producing labelled proteins could be applied to other types of proteins that
until now could not be studied with NMR due to practical limitations. In future, this may help
scientists to better understand how drugs affect these proteins and to develop new treatments for a
whole range of diseases.
DOI: https://doi.org/10.7554/eLife.28505.002
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A2AR (Ye et al., 2016) provided evidence for at least four different conformational states populated
by these receptors, which are differentially stabilized by ligands of different efficacy. 1H/13C 2D NMR
studies on 13Ce-methionine-labeled b2AR (Nygaard et al., 2013; Kofuku et al., 2014) showed that a
high free-energy barrier exists between inactive and active conformations (with exchange on the mil-
lisecond timescale), and agonist binding alone is only capable of weakly populating the active con-
formation. These studies, in addition to similar measurements on m-opioid receptor chemically
modified to introduce NMR-active 13C-methyl labels onto lysine residues (Sounier et al., 2015), sug-
gest that ligand-activated GPCRs are weakly coupled allosteric systems in which multiple energetic
inputs (i.e. agonist and G protein binding) are required to predominantly populate the active
conformation.
Within the slow millisecond-timescale global interconversion between functional GPCR
conformations (Vilardaga et al., 2003), local structural rearrangements of sidechains in the
receptor (referred to here as ‘microswitches’) have been observed in comparisons of inactive and
active GPCR crystal structures (Katritch et al., 2013), NMR data (Liu et al., 2012a; Manglik et al.,
2015; Ye et al., 2016; Bokoch et al., 2010) and MD simulations (Vanni et al., 2009; Dror et al.,
2011a). The importance of repacking of sidechains from TM3, TM5, and TM6 beneath the ligand
binding pocket, known as the ‘conserved core triad,’ was identified by comparison of structures of
b2AR (Rosenbaum et al., 2011; Rasmussen et al., 2011a) and the m-opioid receptor (Huang et al.,
2015). Further down the TM bundle, an activated microswitch near the site of G protein binding has
been found to represent a common feature of GPCRs that have been crystallized in both active and
inactive conformations (Venkatakrishnan et al., 2016). A working hypothesis for GPCR activation is
that a set of loosely coupled microswitches connecting the orthosteric pocket and G protein binding
site are activated by agonists in a non-concerted fashion, and stabilizing subsets of these rearrange-
ments can lead to alternate overall conformations that have different signaling properties.
One of the most powerful ways to probe sidechain dynamics and their contributions to biological
processes is provided by NMR-based studies of isotopically-labeled methyl groups (Ruschak and
Kay, 2010). To apply these techniques to study the sidechains in these microswitches, one approach
would entail isoleucine/leucine/valine (ILV) labeling (Goto et al., 1999; Gardner et al., 1998) and
perdeuteration of a wild-type GPCR, to generate proteins with 1H/13C-labeled methyl groups within
an otherwise 2H/12C-labeled background. Such samples are ideally suited for acquiring 1H/13C
methyl TROSY-based (Tugarinov et al., 2003a; Ollerenshaw et al., 2003) relaxation NMR data,
allowing the quantitative determination of methyl order parameters and relative motion of side-
chains on the ps-ns timescale (Tugarinov et al., 2005; Ishima and Torchia, 2000). Advances in label-
ing methodology and pulse sequences have enabled such measurements on large macromolecular
systems, such as the 80 kDa enzyme malate synthase (Tugarinov and Kay, 2003b; Sandala et al.,
2007), the 670 kDa archaeal proteasome core particle (Sprangers and Kay, 2007; Religa et al.,
2010), and the 1 MDa GroEL/GroES complex (Fiaux et al., 2002; Horst et al., 2005). NMR spectro-
scopic interrogation of methyl groups has also been used to dissect the energetic contribution of
sidechain entropy to important biological phenomena such as protein-protein
interactions (Marlow et al., 2010) and transcription factor binding to double-stranded
DNA (Tzeng and Kalodimos, 2012). These previous applications suggest that characterization of
sidechain dynamics using methyl NMR approaches should be feasible for a GPCR purified in a deter-
gent micelle, with an aggregate molecular weight in the 100–150 kDa range.
A major hurdle in carrying out such experiments is that perdeuteration and ILV labeling conven-
tionally rely on expression in E. coli (Goto et al., 1999), while wild-type GPCRs typically require a
eukaryotic host to ensure proper folding, glycosylation, trafficking, and stability in the plasma mem-
brane. GPCR NMR studies have primarily used supplementation with labeled amino
acids (Nygaard et al., 2013; Kofuku et al., 2014; Okude et al., 2015; Isogai et al., 2016;
Kofuku et al., 2012) or covalent modification (Liu et al., 2012a; Sounier et al., 2015;
Bokoch et al., 2010; Eddy et al., 2016) to incorporate isotopic probes into protein from Sf9 cells,
and perdeuteration with incorporation of labeled ILV methyl probes is largely intractable for this
established eukaryotic system. Another limitation is that purified wild-type GPCRs are typically prone
to aggregation and are not highly thermostable, limiting acquisition times and sample concentration.
While high quality 2D NMR spectra of GPCRs have been obtained for receptors with thermostabiliz-
ing mutations (Isogai et al., 2016), such mutations can affect the receptor’s dynamics and functional
properties, including basal activity and maximal G protein stimulation.
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We have addressed many of these practical issues with our generation (Clark et al., 2015) of
highly-deuterated 1H/13C Ile d1-methyl labeled proteins in Pichia pastoris, a methylotrophic
yeast (Cereghino and Cregg, 2000) that is adaptable to D2O-based minimal media, will utilize the
Ile precursor a-ketobutyrate, and enables expression of GPCRs at levels sufficient for
crystallography (Shimamura et al., 2011; Hino et al., 2012; Yurugi-Kobayashi et al., 2009). Here
we apply this labeling method to the wild-type human A2AR, an important regulator of vascular func-
tion with a well-developed pharmacology including the natural hormone adenosine and high-affinity
synthetic agonists and antagonists (Preti et al., 2015; de Lera Ruiz et al., 2014). A2AR has been
crystallized in inactive (Jaakola et al., 2008; Liu et al., 2012b), intermediate (Lebon et al., 2011;
Xu et al., 2011) and active (Carpenter et al., 2016) conformations, and has been studied by 19F
NMR to characterize its conformational equilibria (Ye et al., 2016). We expressed and purified milli-
gram quantities of labeled wild-type human A2AR and were able to resolve 20 out of 29 expected
peaks in the Ile d1 region in 1H/13C TROSY HMQC experiments. Through structure-guided mutagen-
esis, we assigned four of these signals to specific functionally important residues, including I923.40 of
the conserved core triad (Huang et al., 2015) and I292 at the cytoplasmic surface. We collected
spectra in the presence of the high-affinity full agonist NECA and the inverse agonist ZM241385,
and also measured the effects of monovalent cations (Na+ versus K+) on these spectra. We further
carried out a modified triple-quantum (3Q) relaxation experiment (Sun et al., 2011) to quantify the
relative fast ps-ns motions of these sidechains while the receptor is bound to ligands of opposing
efficacy. These data represent an important first step towards understanding how agonists can acti-
vate the fast motions of specific sidechains to facilitate conformational changes of a GPCR.
Results
The first challenge in collecting methyl NMR spectra on a wild-type GPCR was achieving high-level
expression and milligram scale purification from Pichia pastoris. We initially cloned several
GPCRs (including A2AR) into a modified methanol-inducible expression vector with the wild-type
MFa signal sequence at the N-terminus to direct incorporation into the membrane. Several recep-
tors, such as the wild-type M2 muscarinic receptor and A2AR, showed reliable and reproducible
expression, however much of the expressed proteins were present in the immature unprocessed
form (without MFa cleavage) indicating that they had not been properly localized to the plasma
membrane (Figure 1—figure supplement 1). To improve the efficiency of production of mature,
folded receptors, we made several modifications to the MFa sequence, based on biochemical and
genetic precedents (Rakestraw et al., 2009; Lin-Cereghino et al., 2013) for improved processing
efficiency (Figure 1A, Materials and methods). To validate that Pichia-expressed A2AR is functional,
we carried out radioligand binding assays measuring [3H]-ZM241385 saturation and NECA competi-
tion on membranes after cell wall disruption and zymolyase treatment. The Kd for [
3H]-ZM241385
was 0.42 nM in NaCl-containing buffer, while the Ki for NECA was 210 nM in low ionic strength and
420 nM in KCl-containing buffer, in agreement with previous binding studies (Xu et al., 2011;
Carpenter et al., 2016; Bertheleme et al., 2013) on heterologously expressed A2AR (Figure 1—fig-
ure supplement 2).
We developed a purification protocol for A2AR from Pichia-derived membranes, in which we can
solubilize and purify ~0.5 mg of monodisperse biochemically pure wild-type A2AR in
dodecylmaltoside (DDM) detergent from 1 L of culture (Figure 1—figure supplement 1). Coupling
this protocol with our previously-described labeling method (Clark et al., 2015), we were able to
generate samples of wild-type A2AR that are highly deuterated both within the protein (
2H at non-
exchangeable sites except Ile d1 methyl groups) and the surrounding buffer (99% D2O and deuter-
ated DDM). We prioritized the use of a wild-type A2AR construct to report on the dynamics of a
physiologically and functionally relevant GPCR sample. To confirm that the high level of deuteration
did not alter the receptor’s functional properties, we reconstituted the perdeuterated purified A2AR
together with purified Gs heterotrimer in phospholipid vesicles and carried out activation assays by
[35S]GTPgS binding. Saturating the receptor with the full agonist NECA led to an 8-fold stimulation
of [35S]GTPgS binding, and the inverse agonist ZM241385 produced a 50% reduction in basal activ-
ity, similar to values measured for protonated A2AR (Figure 1B). These data show that the perdeu-
terated A2AR is capable of activating Gs at wild-type levels in vitro, and can serve as a valid model
for GPCR dynamics.
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Our first NMR characterization of A2AR used
1H/13C TROSY HMQC spectra of the protein in the
presence of different ligands or Gs. We initially expressed and solubilized the receptor with the low-
affinity antagonist theophylline, and exchanged other ligands onto the receptor during washing in
the Co2+-affinity and gel filtration steps (Materials and methods). In this way we were able to purify
A2AR samples with the inverse agonist ZM241385, the full agonist NECA, or no ligand. The resulting
2D HMQC spectra, requiring ~100 mM GPCR and a minimum of 2 hr acquisition at 30˚C on a cryo-
probe-equipped 800 MHz spectrometer, are shown in Figure 2. Overall, in a liganded sample, we
could resolve 20 peaks in the Ile d1 region of the spectrum, out of 29 Ile residues present in our con-
struct (28 from the receptor and one from the C-terminal Protein C tag). The chemical shifts of the
agonist-bound and inverse agonist-bound A2AR are similar (Figure 2A,B), showing subtle changes
that are comparable in magnitude to those observed previously for 13C-methyl-methionine probes in
b2AR (Kofuku et al., 2014; Kofuku et al., 2012). The spectrum of the unliganded (apo) A2AR shows
a loss of most of the well-dispersed peaks present in the ligand-bound spectra (Figure 2C), which
could result from protein instability or conformational exchange on the ms-ms timescale. Lastly, we
formed and isolated a high-affinity complex between purified NECA-bound A2AR and purified Gs
heterotrimer in the absence of GDP or GTP (Figure 2—figure supplement 1, Materials and meth-
ods). Like the apo spectrum, the G protein complex spectrum had fewer well-dispersed Ile peaks
Figure 1. A2AR expression and Gs activation. (A) Wild-type A2AR was expressed in P. pastoris as a fusion with an optimized version of the a-mating
factor (MFa) signal sequence that contains mutations and a deletion that increase receptor trafficking to the plasma membrane. For NMR experiments,
Pichia cultures were grown in deuterated media supplemented with (1H/13C-methyl) a-ketobutyrate to facilitate 1H/13C labeling of Ile d1 methyl groups
in a deuterated background as previously described (Clark et al., 2015). Crystal structures of A2AR are shown complexed with agonist NECA (red,
2YDV (Lebon et al., 2011)) and inverse agonist ZM241385 (gray, 4EIY (Liu et al., 2012b), with isoleucine residues displayed as spheres. Labeled Ile d1
carbon atoms are shown in cyan (see inset). (B) [35S]GTPgS binding to purified, protonated or perdeuterated A2AR reconstituted with purified Gs
heterotrimer. Agonist NECA stimulates [35S]GTPgS binding, while inverse agonist ZM241385 inhibits basal levels of binding.
DOI: https://doi.org/10.7554/eLife.28505.003
The following figure supplements are available for figure 1:
Figure supplement 1. A2AR processing and purification.
DOI: https://doi.org/10.7554/eLife.28505.004
Figure supplement 2. Ligand binding assays on A2AR yeast membranes.
DOI: https://doi.org/10.7554/eLife.28505.005
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Figure 2. NMR spectra of A2AR in different liganded states with NaCl. (A)
1H/13C HMQC spectrum of Ile d1-labeled WT A2AR in DDM micelles and 150
mM NaCl with inverse agonist ZM241385 (black). Resonances assigned in this work (I923.40, I2386.40, I2747.39, I292, and the isoleucine residue in the
protein C tag) are indicated with arrows. (B) 1H/13C HMQC spectrum of Ile d1-labeled WT A2AR in DDM micelles and 150 mM NaCl with agonist
NECA (red). See Figure 2—figure supplement 3 for comparison of initial NECA spectrum with spectrum after 7.5 hr acquisition. (C) 1H/13C HMQC
spectrum of Ile d1-labeled WT A2AR in DDM micelles and 150 mM NaCl without ligand (green). (D)
1H/13C HMQC spectra of Ile d1-labeled WT A2AR in
DDM micelles and 150 mM NaCl with agonist NECA (red) and with agonist NECA and Gs heterotrimer (blue).
DOI: https://doi.org/10.7554/eLife.28505.006
The following figure supplements are available for figure 2:
Figure supplement 1. A2AR and Gs complex formation.
DOI: https://doi.org/10.7554/eLife.28505.007
Figure supplement 2. Assignments of select Ile-d1 methyl resonances in A2AR.
DOI: https://doi.org/10.7554/eLife.28505.008
Figure supplement 3. Lifetime of A2AR NMR sample.
DOI: https://doi.org/10.7554/eLife.28505.009
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than receptor/ligand complexes (Figure 2D), consistent with the increase in molecular weight of the
complex. We also note the appearance of a few distinct peaks (most prominently at 0.85 ppm 1H,
11.8 ppm 13C) in the G protein complex, consistent with the conformation of the complexed recep-
tor being distinguishable from the apo receptor (Rasmussen et al., 2011b; Carpenter et al., 2016).
Assignment of 1H/13C peaks in the Ile d1 region by NMR was hampered by the modest dispersion
of our spectra and the limited stability of A2AR during data acquisition. Therefore, we took a site-
specific mutagenesis approach, wherein we collected HMQC spectra of samples containing point
mutations at a small subset of functionally important Ile sites (Figure 2 and Figure 2—figure supple-
ment 2). This process was complicated by the sensitivity of the receptor to mutations at several of
these Iles: changes to Val, Leu, or Met often drastically reduced purification yields and/or led to sig-
nificantly altered spectra; for an example, see the I106V spectra in Figure 2—figure supplement 2.
Three of the assignments (I923.40, I2386.40, and I292) could be made primarily through observation of
ZM241385-bound mutant spectra. By comparing WT and I92V spectra in the presence of ZM241385,
we see a clear loss of signal at ~0.68ppm/13.6ppm (1H/13C) that we can assign to the d1 methyl of
Ile92. The NECA-bound I92V spectrum is missing a subset of peaks compared to the ZM241385-
bound spectrum, possibly due to compromised affinity of NECA for the I92V mutant (Figure 1—fig-
ure supplement 2D). Ile238 and Ile292 are well-dispersed peaks, allowing for unambiguous assign-
ment through loss of peaks at 0.72 ppm/10.2 ppm and 1.12 ppm/12.7 ppm, respectively (1H/13C).
The mutant spectra of I2386.40 and I292 have reciprocal effects on each other, where I238V causes a
full peak-width shift in the I292 signal (upfield in 1H), and I292L causes a ~ 0.5 peak-width shift in the
I238 signal (upfield in 13C). The reciprocity between these mutant spectra is consistent with the prox-
imity of these residues in the A2AR structure. Mutation of I274
7.39 in the ligand binding
pocket (within van der Waals contact of the ligands in the respective crystal structures) to Val or Met
led to a disappearance of some peaks, reminiscent of the apo spectrum. However, comparison of
ZM241385-bound I274M and I274V spectra narrowed the choice of the assignment of I2747.39 to
one of two peaks, with the greater solvent accessibility as revealed by solvent PRE effect (see below
and Figure 4) of one peak serving as the deciding factor of assignment at 0.55 ppm/14.1
ppm (1H/13C). As well as disappearance of many peaks, the spectrum of I274M A2AR in the presence
of ZM241385 displays several apparent peak doublings, suggesting that the mutant protein is under-
going slow conformational exchange, potentially related to the slow interconversion between differ-
ent inactive states of the receptor (Ye et al., 2016). In addition, we assigned a peak to the Ile
residue of the C-terminal Protein C tag in our construct by comparing spectra between differently
tagged constructs (not shown). The remaining unassigned peaks are referred to as a-o in the rest of
this work (Figure 3A). The chemical shift changes between ZM241385-bound and NECA-bound
A2AR are small overall (Figure 2A,B). In the A2AR-Gs complex spectrum (Figure 2D), the peak for
I923.40 appears to shift and simultaneously drop in intensity, strongly suggesting that I923.40 is
involved in conformational changes on several timescales while the receptor is bound to Gs.
A2AR contains a well-characterized Na
+ binding site within the receptor core (Liu et al., 2012b),
and Na+ has been shown to act as a negative allosteric modulator of A2AR activation (Gao and Ijzer-
man, 2000). Due to the presence of 150 mM NaCl in the experiments shown in Figure 2, one possi-
ble explanation for the relatively small chemical shift differences between NECA- and ZM241385-
bound spectra (Figure 3A,B) is that high [Na+] is suppressing structural changes in the agonist-
bound receptor. To test this possibility, we acquired HMQC spectra for A2AR samples with 150 mM
KCl substituting for NaCl. The spectrum of ZM241385-bound receptor in KCl is very similar to that in
the presence of NaCl (Figure 3C and Figure 3—figure supplement 1B), with the peak assigned to
I923.40 shifting slightly upfield in the 13C dimension. The spectrum of NECA-bound A2AR, on the
other hand, is dramatically different in KCl and NaCl (Figure 3D, Figure 3—figure supplement 1D),
with multiple peaks shifting and decreasing in intensity. However, the KCl samples were significantly
less stable than those in NaCl, showing markedly decreased spectral quality after 1 (NECA-bound)
or 2 (ZM241385-bound) hours of acquisition. Given the weak signal-to-noise and poor stability of the
KCl samples, we were only able to perform NMR relaxation experiments (below) on A2AR in the
presence of NaCl.
In addition to ligand-induced chemical shift changes, we used our system to characterize the sol-
vent accessibility of residues within the ZM241385-bound A2AR (with NaCl) using solvent paramag-
netic relaxation enhancements (PREs). To do so, we used the soluble paramagnetic Gd3+-DTPA
probe (Petros et al., 1990), which enhances the relaxation rates of protons in a distance dependent
Clark et al. eLife 2017;6:e28505. DOI: https://doi.org/10.7554/eLife.28505 7 of 27
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Figure 3. Ligand- and cation-dependent chemical shift changes in A2AR. (A)
1H/13C HMQC spectrum of Ile d1-labeled WT A2AR in DDM micelles and
150 mM NaCl with inverse agonist ZM241385 (black). Residue numbers of assigned peaks and peak IDs of unassigned peaks are indicated in black. (B)
1H/13C HMQC spectrum of Ile d1-labeled WT A2AR in DDM micelles and 150 mM NaCl with agonist NECA (red). (C)
1H/13C HMQC spectrum of Ile d1-
labeled WT A2AR in DDM micelles and 150 mM KCl with inverse agonist ZM241385 (brown). (D)
1H/13C HMQC spectrum of Ile d1-labeled WT A2AR in
DDM micelles and 150 mM KCl with agonist NECA (purple).
DOI: https://doi.org/10.7554/eLife.28505.010
The following figure supplement is available for figure 3:
Figure 3 continued on next page
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manner within roughly 15 Å of the protein/solvent interface (Madl et al., 2011). By acquiring 1H/13C
TROSY HMQC spectra in the absence and presence of Gd3+-DTPA, we could compare peak intensi-
ties between the two to establish solvent PRE levels. Examining our data, we see that the average
peak intensity in the Gd3+-DTPA containing spectrum is about 0.4 of that in the control spectrum,
suggesting that the Ile d1 methyl groups of A2AR in the DDM micelle are quite close to solvent on
average (Figure 4). Of the four most strongly affected peaks, three peaks correspond to assigned
residues (I2386.40, I2747.39, and I292). The accessibility of I2747.39 is expected due this amino acid’s
presence in the solvent-exposed ligand-binding pocket. Broadening of I292 at the junction between
TM7 and Helix 8 is also somewhat expected due to its position at the cytoplasmic surface. The
broadening observed for I2386.40 is more surprising, given that it is further embedded within the
membrane and buried within the protein surface of A2AR. Crystal structures of multiple GPCRs,
including A2AR, b2AR, mOR, and rhodopsin have all revealed ordered solvent networks within the
protein core in contact with the position equivalent to I2386.40. In ZM241385-bound A2AR, this resi-
due is also in close proximity to the Na+ site (Liu et al., 2012b), one packing layer toward the cyto-
plasmic surface. The solvent PRE effect seen for this residue could reflect breathing of the structure
to expose this region to the Gd3+-DTPA complex.
To characterize the motions of the Ile sidechains within A2AR, we sought to carry out a triple
quantum (3Q) relaxation experiment developed by Kay, Tugarinov and colleagues (Sun et al., 2011)
to quantify sidechain dynamics in large macromolecules. In this experiment, two related series of 2D
1H/13C HMQC-based spectra were acquired, both of which start by generating transverse 1H mag-
netization composed of single quantum (SQ) coherences. During a subsequent variable delay period,
Figure 3 continued
Figure supplement 1. Overlays of ligand- and cation-dependent chemical shift changes in A2AR.
DOI: https://doi.org/10.7554/eLife.28505.011
Figure 4. Solvent PRE analysis of A2AR. (A) Solvent PRE
1H/13C HMQC spectra of Ile d1-labeled WT A2AR in DDM micelles with inverse agonist
ZM241385 in the presence (red) and absence (black) of paramagnetic Gd3+-DTPA. Disappearance of peaks suggests solvent exposure. (B) Plot of
intensity ratios between paramagnetic and diamagnetic samples for 20 peaks in the Ile d1 region of the HMQC for A2AR complexed with inverse
agonist ZM241385. The average (± 1 standard deviation) intensity ratio is shown as solid (dashed) black lines. Error bars show errors propagated from
the noise of the NMR spectra. Assigned peaks are on the left of the plot, unassigned on the right. Peak IDs correspond to those in Figure 3A.
DOI: https://doi.org/10.7554/eLife.28505.012
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intra-methyl 1H 1H dipolar cross-correlated relaxation mechanisms lead to a portion of these SQ
coherences evolving into 3Q coherences; the rate of this conversion (h) is proportional to the S2axis
methyl order parameter. Practically, the degree of SQ->3Q evolution can be quantitated by examin-
ing paired ‘forbidden’ and ‘allowed’ spectra, which report on the fraction of SQ coherences which
do and do not evolve into 3Q coherences, respectively. As previously reported (Sun et al., 2011),
this allows the simple calculation of the h rate for each specific methyl group from the ratio of peak
intensities in the forbidden and allowed spectra. Our initial attempts to apply this method to purified
A2AR were hampered by the fact that the wild-type receptor is insufficiently stable at 30˚C to permit
the measurement of the requisite paired spectra at many relaxation delays and with a high enough
signal-to-noise ratio. We therefore explored the possibility of reducing the number of forbidden
spectra required to accurately measure h values. Using similarly 2H,12C (1H,13C d1 methyl) labeled
maltose binding protein (MBP) as a test case (Materials and methods), we collected 3Q datasets
with different numbers of forbidden spectra paired with a constant number of allowed
spectra (Figure 5, Figure 5—figure supplement 1). We found that pairing five allowed spectra with
a single forbidden spectrum, we were able to faithfully recapitulate the h values measured using five
pairs of forbidden and allowed experiments (Figure 5B,C). This h value is proportional to the S2axis
order parameter, which quantifies the amplitude of motion of the methyl group on the ps-ns time-
scale that is faster than global molecular tumbling.
With this modified analysis of 3Q relaxation data and our Ile d1 1H/13C-methyl-labeled and deu-
terated GPCR samples, we measured h values for Ile sidechains in A2AR bound to either ZM241385
or NECA in NaCl. The resulting values for the 20 Ile peaks and relative changes between the samples
with different ligands are shown in Figure 6. The error in these measurements is large due to the
limited signal-to-noise of our A2AR spectra, and we did not attempt to convert these
h measurements to S2axis values. However, in comparing the two datasets some features of the Ile
dynamics can be discerned. The average h value for the ZM241385-bound sample is higher than for
NECA, indicative of greater overall rigidity of sidechains with inverse agonist. At the individual resi-
due level, we observe a diversity of ligand-dependent changes in h, with some Ile residues becoming
more rigid with agonist while most become more flexible. As an internal control, the peak we
assigned to the C-terminal Protein C tag shows the lowest h value measured (i.e. greatest flexibility)
with little ligand-dependence. Among the other assigned peaks, I292 shows the largest difference
between ligands, becoming more flexible in the NECA-bound sample. I923.40 and I2747.39 display
more modest increases in flexibility with agonist, while the dynamics of I2386.40 are largely
unchanged by ligand (Figure 6B). Interestingly, these differences in fast timescale dynamics occur in
the presence of NaCl, in which chemical shifts for the agonist- and inverse agonist-bound states
were nearly identical. To our knowledge, these data represent the first reported effort to experimen-
tally quantify site-specific sidechain dynamics in a GPCR or comparable human integral membrane
protein.
While we were able to measure sidechain dynamics in this challenging A2AR sample, the associ-
ated errors are quite large. As such, we turned to molecular dynamics (MD) simulations to provide
independent validation of our dynamics measurements. We extracted S2axis order parameters for Ile
d1 methyl groups from ~80 ns trajectories (post-equilibrium) of ZM241385- and NECA-bound A2AR
in DDM micelles, using overlapping 30-ns windows to estimate the standard deviation in the order
parameters (Figure 6—figure supplement 1). The S2axis order parameters for some methyl
groups (for example, I60 and I80 in ZM241385; I106 and I302 in NECA) show significant variations
across different windows, suggesting that slower timescale motions involving these residues contrib-
ute to the sidechain dynamics measured on the fast timescale. Interestingly, the differences between
ZM241385- and NECA-bound dynamics at three of the four assigned sites (I2386.40, I2747.39, and
I292) are qualitatively similar to what we see by NMR. The fourth site, I923.40, shows the opposite
trend, with higher S2axis, i.e. more rigidity, in the NECA-bound state. The simulations were set up
with bulk Na+ ions, but none specifically occupying the binding site near I923.40, which could account
for this discrepancy.
Discussion
Sidechain dynamics represent an important functional component of protein behavior. In cases of
protein-ligand (Marlow et al., 2010; Frederick et al., 2007) and protein-DNA (Tzeng and
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Figure 5. Modified 3Q relaxation for MBP. (A) Crystal structure of MBP complexed with b-cyclodextrin (PDB 1DMB[Sharff et al., 1993]). The b-
cyclodextrin ligand is shown as orange sticks, while protein isoleucine residues are shown as blue sticks, with d1 carbon atoms as spheres. (B) Plot of h
values for each peak in MBP obtained from forbidden:allowed ratios at all five time points (gray) and the single 8 ms time point (green). Values
calculated using the ratio at the single 8 ms time point show good agreement with those calculated using ratios at all five time points. (C) Box-and-
Figure 5 continued on next page
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Kalodimos, 2012) interactions that have been intensively studied, changes in entropy arising from
modified sidechain dynamics in complexes were found to substantially contribute toward the overall
free energy of binding. For GPCRs, changes in sidechain dynamics may play an energetic role in
binding to ligands and G proteins, however we have focused on allosteric mechanisms connecting
these two functionally important binding sites. To experimentally assess the roles of sidechain
dynamics in a wild-type GPCR, we set out to create a labeled sample that would be amenable to
relaxation NMR methods. The spectra we obtained for the labeled Ile d1 methyl groups of perdeu-
terated A2AR are comparable or superior to previously published NMR spectra on other wild-type
GPCRs, however the limited dispersion and signal-to-noise contributed to significant error in the
relaxation values derived from the data (Figure 6A).
The Na+ site first seen in the high-resolution structure of A2AR bound to ZM241285 is conserved
throughout most Class A GPCRs, and Na+ exerts a negative allosteric effect on A2AR activation by
bridging residues on TM3 and TM7 and stabilizing the inactive conformation (Liu et al., 2012b). This
effect can be observed pharmacologically as a NaCl-dependent decrease in agonist
affinity (Carpenter et al., 2016; Gao and Ijzerman, 2000). For A2AR expressed in P. pastoris, we
observe a 9-fold decrease in NECA affinity when membranes are incubated in 150 mM NaCl buffer
versus 150 mM KCl buffer (Figure 1—figure supplement 2), similar to previously reported
values (Carpenter et al., 2016). Several of the Ile residues that we assigned (i.e. I923.40 and I2386.40)
are in close proximity to the Na+ binding site, which should make for sensitive probes of local struc-
ture in this part of the receptor core. Our 2D NMR spectra indicate a strong dependency on com-
bined lack of Na+ and binding of agonist to stabilize significant structural changes in the receptor
core (Figure 3). This observation is also consistent with the active conformation seen in the crystal
structure of the A2AR/mini-Gs complex (Carpenter et al., 2016), which results in collapse of the Na
+
site due to inward movements of TM3 and TM7. In contrast to our data, the crystal structure of a
NECA-bound thermostabilized A2AR mutant construct (Lebon et al., 2011) showed significant struc-
tural changes relative to the inactive conformation even with a high [Na+] beyond its EC50 (~50 mM)
for negative allosteric modulation (Gao and Ijzerman, 2000). Unfortunately the weak signal and sta-
bility of our samples in KCl precluded measurement of 3Q relaxation dynamics under these
conditions.
For the Na+-bound A2AR samples, we can correlate our observations of ligand-dependent
changes in the relaxation rate of specific sites to previous structural and biophysical studies of
GPCRs. I2747.39 at the ligand binding site makes direct contact with the adenine or adenine ana-
logue rings of both NECA and ZM241385 in their respective crystal structures (Jaakola et al., 2008;
Liu et al., 2012b; Lebon et al., 2011; Carpenter et al., 2016) (Figure 7A). In our relaxation data-
sets, I2747.39 was more rigid in terms of its fast sidechain motions with inverse agonist bound, and
more flexible with NECA occupying the binding pocket. NMR experiments previously showed differ-
ent ligand-dependent conformations of the extracellular surface region of b2AR bound to agonists
compared to inverse agonists (Bokoch et al., 2010). In addition, MD simulations on b2AR predicted
greater mobility of agonists relative to inverse agonists in the orthosteric pocket of the inactive-state
structure (i.e. not bound to Gs) (Dror et al., 2011b). Our data suggests that the fast dynamics of res-
idues at the orthosteric pockets of Class A GPCRs may be correlated with the functional efficacy of
the bound ligand. The residue I923.40 is one of the three residues of the conserved core triad in
A2AR, along with P189
5.50 and F2426.44, which interact at a layer beneath the orthosteric pocket fur-
ther toward the cytoplasmic surface (Figure 7B). Consistent with the rearrangements of this micro-
switch region between the inactive and active conformations of multiple GPCRs, we observe a lower
h value for I923.40 in the NECA dataset versus ZM241385, indicating greater sidechain flexibility
Figure 5 continued
whisker plot showing Ile d1 S2axis values from a set of globular proteins (Mittermaier et al., 1999) (purple) and the S
2
axis values calculated from the h
values using ratios at all time points (gray) and the single 8 ms time point (green).
DOI: https://doi.org/10.7554/eLife.28505.013
The following figure supplement is available for figure 5:
Figure supplement 1. Adaptation of 3Q methyl relaxation experiment to A2AR samples.
DOI: https://doi.org/10.7554/eLife.28505.014
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Figure 6. Changes in dynamics of methyl groups of A2AR in the presence of different ligands. (A) Plot of the
1H-1H dipolar cross-correlation rateh,
which is proportional to the S2axis order parameter, for 20 peaks in the Ile d1 region for A2AR in DDM micelles with agonist NECA (red) and inverse
agonist ZM241385 (grey). A higher h value corresponds to more rigid methyl groups. Error bars show bootstrap errors of the fit parameters,
propagated from the noise of the NMR spectra. Assigned peaks are on the left of the plot, unassigned on the right. Peak IDs correspond to those in
Figure 6 continued on next page
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when A2AR is agonist-bound. In several GPCRs, including b2AR and mOR, the conserved core triad is
unchanged at a static structural level with an agonist bound but without a G protein or nanobody to
further stabilize the active conformation. In contrast, crystal structures of A2AR bound to agonists
alone (Figure 7B) showed an intermediate active-like conformation in the region surrounding
I923.40 (Lebon et al., 2011; Xu et al., 2011). Our data indicate that low [Na+] is required for NECA
alone to stabilize structural rearrangements surrounding I92 (Figure 3, Figure 3—figure supple-
ment 1). However agonist alone (even with high [Na+]) is enough to at least promote the fast
motions of the sidechains in this microswitch, which may reduce the activation energy for the
observed packing rearrangement to the active conformation.
The residue I2386.40 is situated further toward the G protein binding site at a critical region for
GPCR activation, where it packs against TM7 and undergoes significant outward movement in the
transition to the active conformation (Figure 7C). I2386.40 is also one helical turn on TM6 above
L2356.37, which participates in a conserved microswitch between inactive and active conformations
for multiple GPCRs (Venkatakrishnan et al., 2016). I292 is present at the linker between TM7 and
Helix 8, where it packs against Y2887.53 of the highly conserved NPXXY motif (Katritch et al.,
2013) (Figure 7D). NMR studies of 13C-dimethyllysine-labeled mOR showed that peak broadening of
a lysine probe in Helix 8 (near the position equivalent to I292) was more sensitive to agonist than
probes at the cytoplasmic ends of TM5 and TM6 (21). Further, in the structure of A2AR/mini-
Gs (Carpenter et al., 2016), the engineered Gs protein makes direct contact with I292 at the TM7-
Helix 8 junction. In our relaxation dataset, the h value of I2386.40 is low (i.e. more flexible) and essen-
tially independent of the ligand, while I292 undergoes a large change from more rigid to more flexi-
ble from ZM241385 to NECA. As mentioned above, the environment surrounding I2386.40 is loosely
packed in A2AR structures, with an ordered solvent network that may allow for relative freedom of
motion for this sidechain. In contrast, despite the solvent exposure of I292 (Figure 4), inverse agonist
binding suppresses the fast dynamics of this residue relative to agonist binding (Figure 6). Outward
movement of TM6 is one of the hallmarks of GPCR activation seen in crystal structures, and the cyto-
plasmic ends of TM6 and TM7 are separated from each other in the structures of b2AR and A2AR
bound to Gs (Rasmussen et al., 2011b; Carpenter et al., 2016). Our data suggest that the respon-
siveness of sidechain dynamics to ligands in these two regions may be largely uncoupled, and that
the inverse agonist activity of ZM241385 could partly arise from its allosteric suppression of dynam-
ics at the cytoplasmic end of TM7. Changes in h for other peaks in our dataset may provide further
insights into the regulation of different regions of the receptor by ligands, depending on assignment
of the other Ile residues in our spectra.
Beyond our studies of the A2AR, we can now apply the methods for labeling and NMR spectros-
copy described here to other GPCRs and eukaryotic membrane proteins. Since the microswitches
discussed above were identified by comparison of different GPCR structures (Huang et al., 2015;
Venkatakrishnan et al., 2016), it will be instructive to apply our methods to other receptors to see
if the same patterns of ligand-dependent changes apply across the GPCR superfamily or change
depending on the cognate ligand or preferred G protein signaling partner. Further, sidechain
dynamics may be among the biophysical properties of GPCRs that are altered when receptors are
bound to allosteric modulators or biased agonists, classes of ligands that are of increasing value and
importance in GPCR pharmacology and drug development. In addition to GPCRs, many other dis-
ease-relevant human integral membrane proteins (such as ABC transporters and ion channels) are
currently impossible to study by NMR methods, largely due to the challenges of expression, label-
ing, and perdeuteration in E. coli. Our approach has the potential to make these systems tractable
for similar NMR measurements of sidechain dynamics.
Figure 6 continued
Figure 3A. (B) Plot of the ligand-induced differences (Dh = h[NECA] – h[ZM241385]) for 20 peaks in the Ile d1 region for A2AR in DDM micelles.
Negative Dh values, which are observed for the majority of peaks, indicate increased motions in the presence of agonist. Assigned peaks are on the left
of the plot, unassigned on the right. Peak IDs correspond to those in Figure 3A.
DOI: https://doi.org/10.7554/eLife.28505.015
The following figure supplement is available for figure 6:
Figure supplement 1. Changes in dynamics of methyl groups of A2AR in the presence of different ligands from MD trajectories.
DOI: https://doi.org/10.7554/eLife.28505.016
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Figure 7. Structural contexts of isoleucine peak assignments. A2AR ribbon diagrams are shown for structures solved in complex with inverse agonist
ZM241385 (gray; PDB 4EIY[Liu et al., 2012b]), agonist NECA (red; PDB 2YDV[Lebon et al., 2011]), and agonist UK432097 (orange; 3QAK[Xu et al.,
2011]). Assigned isoleucine residues are shown as spheres for the ZM241385- and NECA-bound structures using the same coloring scheme as in
Figure 1A. Additional highlighted residues are shown as sticks in B-D. (A) Isoleucine 274 is part of the orthosteric binding pocket and makes direct
contact with the adenine analogue and adenine rings in ligands ZM241385 and NECA, respectively (shown as sticks). (B) Isoleucine 92 sits below the
binding pocket and interacts with nearby residues Pro189 and Phe242. Ile92, Pro189, and Phe242 all make structural rearrangements upon receptor
activation. (C) On TM6, assigned peak Ile238 is one helical turn above Leu235. Leu235 is part of a conserved microswitch region that that undergoes
outward motion during the transition to the active state. (D) Isoleucine 292 is at the cytoplasmic end of TM7 where it interacts with Tyr288, also part of
the conserved NPXXY motif.
DOI: https://doi.org/10.7554/eLife.28505.017
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Materials and methods
Construct design
The cDNA for wild-type human ADORA2A adenosine A2A receptor was cloned into the pPICZ vector
for expression in Pichia pastoris with a modified MFa secretion signal combining previous
precedents (Rakestraw et al., 2009; Lin-Cereghino et al., 2013). Modifications to the MFa greatly
increased the amount of fully-processed receptor present at the plasma membrane. Briefly, the
mutations V22A, G40D, L42S, V50A, V52A, and F55L were introduced, and residues 57–70 were
removed from the signal sequence. The receptor expression construct was terminated at residue
316 and the N-glycosylation site at Asn154 was mutated to glutamine (Jaakola et al., 2008). The
gene for the receptor was followed by a 8x His tag and a Protein C tag at the C-terminus. All point
mutations were created using standard QuikChange protocols. Plasmids were linearized by incuba-
tion with PmeI (NEB) and inserted via electroporation into freshly prepared competent KM71H
cells (Invitrogen, https://www.thermofisher.com/order/catalog/product/C18200). Clones were
screened for integration efficiency with increasing amount of Zeocin (Invitrogen) in selection media
and further selected through expression screens and western blots. The best expressing clones were
stored as glycerol stocks at  80˚C. As these yeast clones were only used for protein expression/puri-
fication and membrane preparation for binding assays, no authentication or mycoplasma contamina-
tion testing was performed.
Expression of protonated cultures
For large scale growth in natural abundance media, a small amount of freshly streaked cells was
inoculated into a 10 mL culture of BMGY media (1% glycerol, 100 mM potassium phosphate pH 6.0,
1.34% YNB (yeast nitrogen base), 0.004% histidine, 4  10 5% biotin) and shaken at 28˚C overnight
at 250 rpm. The pilot culture was used to inoculate multiple liters of BMGY and shaken until satura-
tion is reached (OD600 ~20–30). The total culture was spun down in sterile bottles at 4000 rpm for 30
min and resuspended in equal volume of BMMY media (100 mM potassium phosphate pH 6.0,
1.34% YNB, 0.004% histidine, 4  10 5% biotin) without methanol. Cultures continued shaking
for ~8 hr at 28˚C to allow for metabolism of residual glycerol. Protein expression was induced with
the addition of 0.5% v/v methanol and the temperature was reduced to 20˚C. An additional 0.5%
methanol was added every 12 hr to maintain expression. Cells were harvested after 36–48 hr and
pelleted by centrifugation. Pellets were stored at  80˚C.
Expression of deuterated cultures
For expression of cells in deuterated cultures, the cells were first adapted to deuterated media as
follows. A small amount of freshly streaked cells was inoculated into a 50 mL culture of BMGY con-
taining 90% D2O/10% H2O (Cambridge Isotope Laboratories, Inc., Tewksbury MA). The culture was
shaken at 28˚C until an OD600 of 8–10 was reached (typically ~24 hr). Once that OD was reached,
200 mL of the 90%/10% culture was inoculated into 50 mL of BMGY media made with 100% D2O
and protonated glycerol. The culture was shaken at 28˚C until an OD600 of 8–10 was
reached (typically ~48 hr). 200 mL of the 100% culture was inoculated into 50 mL of BMGY media
made with 100% D2O including d8-glycerol as the carbon source (Cambridge Isotope Laboratories,
Inc.). This culture was incubated until reaching an OD600 of ~10 and the entire culture was inoculated
into large scale cultures of BMGY media again made with 100% D2O including d8-glycerol. The large
scale cultures were shaken until saturation (OD600 of ~20–30) and then spun down in sterile bottles
at 4000 rpm for 30 min. The cells were resuspended in BMMY made in 100% D2O without methanol
and continued shaking for 12–16 hr to metabolize residual d8-glycerol. One hour prior to induction,
200 mg/L of labeled a-ketobutyric acid (methyl-13C, 99%; 3,3-D2, 98%; Cambridge Isotope Labora-
tories, Inc.) was added to the culture. Ten minutes prior to induction, dry theophylline was added to
the culture to a final concentration of 4 mM. Protein expression was induced with the addition of
0.5% d4-methanol (Cambridge Isotope Laboratories, Inc.) and the temperature was reduced to 20˚C.
Expression was maintained by further additions of 0.5% d4-methanol every 12 hr, and cells were har-
vested by centrifugation after 36–48 hr and stored at  80˚C.
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Purification
Cell pellets were thawed and resuspended in lysis buffer (PBS containing 10% glycerol, 4 mM the-
ophylline, 2 mM EDTA, and protease inhibitors (160 mg/mL benzamidine, 2.5 mg/mL leupeptin, 1
mM PMSF, 1 mM E-64)). Cells were passed through a high-pressure microfluidizer (Microfluidics
M-110P) three times at 24,000 psi with a cooling period between passes. LongLife Zymolyase (G-Bio
Sciences) was added to the total lysate at a concentration of 15 U/mL and stirred at 37˚C for 1 hr.
Total membranes were isolated by centrifugation at 140,000 rcf for 30 min and then washed by
douncing in an equal volume of lysis buffer followed by an additional centrifugation step. Mem-
branes were then resuspended in hypotonic buffer (10 mM HEPES pH 7.5, 2 mM EDTA, 4 mM the-
ophylline, protease inhibitors) by douncing and stirred at 4˚C for 30 min, followed by centrifugation
again to isolate membranes. Membranes were dounced in buffer containing 500 mM NaCl, 50 mM
HEPES pH 7.5, 20% glycerol, 1% DDM (Anatrace), 4 mM theophylline, and protease inhibitors and
stirred for 2 hr at 4˚C. Insoluble material was spun out by centrifugation at 140,000 rcf for 30 min.
The resultant supernatant was incubated with TALON resin (Clontech, Mountain View CA) pre-equili-
brated in 250 mM NaCl, 50 mM HEPES 7.5, 0.05% protonated DDM, 5% glycerol, 4 mM theophyl-
line, and 30 mM imidazole. Additional imidazole was added to the supernatant to the final
concentration of 30 mM to minimize background binding. Batch binding continued overnight at 4˚C.
Following batch binding, the resin was washed with a series of buffers to exchange the proton-
ated DDM into deuterated DDM and exchange on the high affinity ligands ZM241385 or NECA. Buf-
fers were made in D2O and all contain 250 mM NaCl, 50 mM HEPES pH 7.5, 5% glycerol, 0.05%
DDM (protonated or deuterated; Anatrace), 20 mM imidazole, and 10 mM ZM241385 or 20 mM
NECA (Tocris). Buffers contain different ratios of protonated:deuterated detergents, and were
added sequentially: (A) 4:0; (B) 3:1; (C) 2:2; (D) 1:3; (E) 0:4. Protein was eluted from TALON with
buffer E + 250 mM imidazole. Eluted A2AR was concentrated in 100 kDa MWCO Amicon
concentrators (Millipore) and injected on a Superdex200 column (GE Healthcare, Chicago IL) equili-
brated in 150 mM NaCl, 20 mM HEPES pH 7.5, 0.05% deuterated DDM, and 10 mM ZM241385 or
20 mM NECA made in D2O. Samples for KCl experiments were purified in the same manner, only
substituting 150 mM KCl instead of NaCl in the SEC buffer.
Previous studies have shown the importance of using cholesterol hemisuccinate (CHS) as a com-
ponent of the micelle to preserve A2AR function (Weiss and Grisshammer, 2002) and increase the
thermostability of the receptor (Liu et al., 2012b). However, when CHS was included in our purifica-
tion, we observed significant artifacts in the Iled1 region of our NMR spectra that hampered data
collection and analysis. Ye et al. utilized an XAC ligand affinity column as an additional chromatogra-
phy step during purification (Ye et al., 2016) that we did not include in this study. Our purification is
similar to what has been published in structural studies of A2AR, following a general purification
scheme of IMAC followed by size exclusion chromatography prior to crystallization in
detergent (Hino et al., 2012; Carpenter et al., 2016; Sun et al., 2017) or lipidic cubic
phase (Jaakola et al., 2008; Liu et al., 2012b; Xu et al., 2011). These structures contain A2AR
bound to agonists, antagonists, or in complex with an engineered ‘mini-Gs’ protein. Given our bio-
chemical evidence (Figure 1—figure supplement 1, Figure 2—figure supplement 1), we are confi-
dent that our purification protocol outlined above produces a high level of folded and functional
A2AR, which is able to efficiently bind to GS in solution.
G protein expression and purification
Gs heterotrimer was purified from Trichoplusia ni cells grown in ESF921 media (Expression Systems).
Cells were lysed in hypotonic buffer containing 10 mM Tris pH 7.4, 100 mM MgCl2, 5 mM b-mercap-
toethanol, 10 mM GDP, and protease inhibitors. After centrifugation, membranes were dounced and
solubilized in buffer containing 100 mM NaCl, 20 mM HEPES pH 7.5, 1% sodium cholate, 0.05%
DDM, 5 mM MgCl2, 5 mM b-mercaptoethanol, 10 mM GDP, 5 mM imidazole, protease inhibitors,
and a 1:150,000 vol dilution of CIP (NEB).
The soluble material was incubated with pre-equilibrated Ni2+-NTA resin for 2 hr at 4˚C. Deter-
gent exchange into deuterated DDM was performed on-column by mixing volumes of buffer E1 (100
mM NaCl, 20 mM HEPES pH 7.5, 1% sodium cholate, 0.05% deuterated DDM, 5 mM MgCl2, 5 mM
b-mercaptoethanol, 10 mM GDP, 20 mM imidazole, protease inhibitors) and buffer E2 (50 mM NaCl,
20 mM HEPES pH 7.5, 0.1% deuterated DDM, 1 mM MgCl2, 5 mM b-mercaptoethanol, 10 mM GDP,
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20 mM imidazole, protease inhibitors) in the following E1:E2 ratio: 1:1; 1:3; 1:9; 1:19 at a flow rate of
1 mL/min. Gs was eluted with buffer E2 supplemented with 200 mM imidazole. Following elution,
MnCl2 was added to a final concentration of 1 mM, and the pooled eluate (~10 mL volume) was incu-
bated with 10 mL lambda phosphatase, 1 mL CIP, and 1 mL Antarctic phosphatase for 30’ at 4˚C. Sam-
ple was diluted with buffer E2 to reduce imidazole concentration and applied to a pre-equilibrated 2
mL Q-sepharose column. The resin was washed with 6 CV of 100 mM NaCl, 20 mM HEPES pH 7.5,
0.04% deuterated DDM, 1 mM MgCl2, 100 mM TCEP, 10 mM GDP and eluted with wash buffer sup-
plemented with an additional 250 mM NaCl. Eluted sample was concentrated in a 10 kDa MWCO
concentrator to 1 mL and diluted 1:1 with buffer containing 20 mM HEPES pH 7.5, 1.5 mM EDTA,
1.65 mM MgCl2, 100 mM TCEP, 1 mM GDP to reduce final DDM and NaCl concentrations. Glycerol
was added to 20%, and aliquots were flash frozen in LN2 and stored at  80˚C until needed. Func-
tional Gs was conservatively estimated to constitute at least 40% of the total purified sample.
A2AR-Gs complex formation
A2AR-Gs complex formation was carried out as follows. SEC-purified A2AR was mixed with Gs at a
1:8 w/w ratio in the presence of 1 mM EDTA, 3 mM MgCl2, 10 mM NECA, 1 mM MnCl2, and a 1:100
dilution of lambda phosphatase (NEB). The complex was incubated at room temperature for 1 hr,
then apyrase (NEB, Ipswich MA) was added at a 1:2000 vol dilution followed by an additional hour
incubation at room temperature. CaCl2 was added to a final concentration of 2 mM and loaded at a
flow rate of 10 mL/hr on Protein C antibody resin (Sigma-Aldrich, St. Louis MO) pre-equilibrated in
150 mM NaCl, 20 mM HEPES pH 7.5, 0.05% DDM, 2 mM CaCl2, 10 mM NECA. ProC resin was
washed with 1 CV buffer at 10 mL/hr, followed by 5 CV buffer at 30 mL/hr. Complex was eluted in 2
CV with 150 mM NaCl, 20 mM HEPES pH 7.5, 0.05% DDM, 10 mM NECA, 5 mM EDTA, 0.2 mg/mL
ProC peptide (EDQVDPRLIDGK). Freshly made TCEP was added to a final concentration of 100 mM
and was spin-concentrated prior to injection on a Superdex200 column equilibrated in 150 mM
NaCl, 20 mM HEPES pH 7.5, 0.05% DDM, and 10 mM NECA.
A2AR-Gs complex formation for NMR proceeded as above with a few modifications. Gs hetero-
trimer purification was carried out as above with the final exchange steps containing deuterated
DDM instead of protonated DDM. Deuterated, labeled, SEC-purified A2AR was mixed with Gs at a
1:8 w/w ratio in the presence of 3 mM MgCl2 in a final volume of 1 mL. The complex was incubated
at room temperature for five minutes, and then a 1/2000 vol of apyrase (NEB) was added. The com-
plex was incubated for an additional hour at room temperature, and then was injected on a Super-
dex200 column incubated in 150 mM NaCl, 20 mM HEPES pH 7.5, 0.05% deuterated DDM, 20 mM
NECA. Peak fractions were concentrated to ~100 mL for NMR experiments.
NMR spectroscopy and analysis
NMR spectra were collected at 30˚C on 50–100 mM A2AR (complexed with ZM241285 or NECA) and
100 mM MBP (complexed with b-cyclodextrin) using a Bruker AVANCE III HD 800 MHz spectrometer
with a cryogenically-cooled TCI probe. All NMR samples were approximately 100 ml in a 3 mm Shi-
gemi tube. NMR data were processed using NMRpipe (Delaglio et al., 1995) and analyzed using
NMRViewJ (Johnson, 2004). Parameters derived from relaxation data were obtained with a non-lin-
ear least-squares fitting programmed in the Python SciPy library (Jones et al., 2001; More, 1977).
Errors in these parameters were generated using a nonparametric Monte Carlo bootstrap
approach (Efron, 1981) with 1000 simulated datasets, each of which consisted of synthetic data-
points with generated values centered on the measured peak intensities (and errors determined
from the noise of the experimental spectra). Each simulated dataset was individually fit; parameters
from these fits were averaged to generate the reported values (as average ± standard deviation).
Unassigned isoleucine methyl peaks in A2AR are referred to by a peak ID (Figure 3A), sorted by
increasing difference between inverse agonist- and agonist-bound relaxation rates (Figure 6B).
1H/13C-HMQC spectra of the methyl region were collected with a 13C spectral width of 22
ppm (8 ppm) centered at 14 ppm (9.5 ppm) for A2AR (MBP), with 32 complex pairs collected. Due to
short sample lifetimes, some A2AR HMQC spectra were collected as several sequential experiments
with 64 scans per t1 point; if peak intensities and locations in these spectra remained consistent (for
example, see Figure 2—figure supplement 3), they were summed after processing. Solvent PRE
experiments were carried out by collecting an HMQC spectrum on an A2AR sample, then adding
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Gd3+ complexed with diethylenetriaminepentaacetic acid (DTPA; Sigma-Aldrich) to a final concentra-
tion of 1 mM and collecting a matched HMQC spectrum. The PRE effect was measured as the ratio
of peak intensities in the paramagnetic sample to those in the diamagnetic sample.
Triple quantum (3Q) relaxation experiments were conducted using a pulse sequence kindly pro-
vided by Prof. Lewis Kay (University of Toronto) (Sun et al., 2011). The carrier was centered on the
methyl region (0.8 ppm) in the 1H dimension, while 13C dimension center and spectral width were as
above for HMQC spectra. The 3Q relaxation experiments were run as pseudo-4D experiments with
the relaxation delays and alternating forbidden/allowed experiments as the third and fourth dimen-
sions. An NMRpipe (Delaglio et al., 1995) script was used to divide the data and process each spec-
trum. For MBP, spectra were collected with relaxation delays of 0.8, 2, 4, 8, and 16 ms for both
forbidden and allowed experiments. Peaks (corresponding to I317 and I333) with low
intensities (defined as less than ten-fold greater than noise in the 16 ms forbidden spectrum) were
not used for relaxation analysis. Peak intensities were measured using the
NMRViewJ (Johnson, 2004) Rate Analysis module by fitting each peak to an ellipse and calculating
the volume. Ratios of peak intensities were fit to the following equation as a function of relaxation





























where N is the number of scans for each experiment, T is the relaxation delay, d (<0) is a term for
the coupling between rapidly and slowly decaying single-quantum coherences, and h is a relaxation











proportional to the methyl axis order parameter S2axis and correlation time tc. All relaxation rates
were constrained to be >0 while d was constrained to be <0.
Due to short lifetimes of A2AR samples (~12–14 hr at 30˚C), the relaxation experiment was modi-
fied and run with five allowed experiments (0.8, 2, 4, 8, and 14 ms) and fewer forbidden experi-
ments. To extract values of h, the forbidden:allowed peak intensity ratios at those few relaxation












where A is a scaling constant, T is the relaxation delay, and RS and RF are as above (Figure 5—
figure supplement 1).
To determine which relaxation delays for the limited forbidden experiments gave values of h that
best agreed with those determined from a full dataset, the MBP relaxation dataset was analyzed
using all five allowed experiments and different combinations of 1 or two forbidden experiments.
The differences in h values for each peak, as well as the sum of squared differences across all peaks,
were compared for each analysis and a single relaxation delay of 8 ms was selected for A2AR relaxa-
tion experiments (Figure 5, Figure 5—figure supplement 1). For processing, two separate scripts
were used to extract the five allowed experiments and sum up the five forbidden experiments.
Allowed peak intensity and forbidden:allowed peak intensity ratios were calculated and fit to Equa-
tions 1 and 2, respectively, as above, to derive values for h at each peak.
Computational methods
Molecular constructs
To construct systems for atomistic molecular dynamics (MD) simulations, we used the X-ray struc-
tures of the human A2A GPCR in complex with agonist NECA or inverse agonist ZM241385 (PDB
accession codes 2YDV (Lebon et al., 2011) and 4EIY (Liu et al., 2012b), respectively). The thermo-
stabilizing agents present in these X-ray models were removed and thermostabilizing mutations in
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the A2AR introduced during the crystallization experiments were reverted back to the corresponding
wild type residues using VMD mutator plugin (Humphrey et al., 1996). Several short residue seg-
ments missing from the X-ray structures were added with Modeller (Sali and Blundell, 1993) to com-
plete the full-length atomistic models of the human A2AR. The Na
+ ion bound to the protein in the
4EIY structure was removed so that the effects of the agonist and the inverse agonist on the protein
dynamics could be directly compared.
Using the protocol we have described earlier (Khelashvili et al., 2013), the NECA- and
ZM241385-bound A2AR structures were inserted into a detergent micelle containing 246 DDM mole-
cules. The resulting proteomicelles were placed in ~1573 Å3 size cubic water box containing 150 mM
NaCl salt. The final molecular systems contained ~330,000 atoms and resulted in detergent concen-
tration of ~0.1 M, well-above established critical micelle concentration (CMC) for DDM (170
mM) (Kaufmann et al., 2006).
Force fields and MD simulations
The all-atom MD simulations were performed with the NAMD 2.7 package (Phillips et al., 2005)
using the all-atom CHARMM27 force-field with CMAP corrections for proteins (Brooks et al., 2009),
and a CHARMM-compatible force-field parameter set for detergents (Abel et al., 2011). CHARMM-
suitable parameters for NECA and ZM241385 compounds were generated with the program
MATCH (Yesselman et al., 2012). Molecular constructs were initially equilibrated using a two-phase
protocol implemented by us earlier for MD simulations of leucine transporter (LeuT)/micelle
complexes (Khelashvili et al., 2013; LeVine et al., 2016): (i) short energy minimization was carried
out during which protein, water, and ion atoms were fixed and the coordinates of only DDM mole-
cules were allowed to evolve freely; and (ii) 1.5 ns long MD simulations were conducted with the pro-
tein backbone harmonically constrained. The constraints were released gradually, in 0.5 ns steps,
with decreasing force constants of 1, 0.5, and 0.01 kcal/ (molÅ2).
After the equilibration phase, both the NECA-bound and ZM241385-bound A2AR systems were
subjected to ~80 ns unbiased MD simulations. Integration steps were 1 fs for the equilibration stage
and 2 fs thereafter. The simulations implemented PME for electrostatics
interactions (Essmann et al., 1995) and were carried out in NPT ensemble under isotropic pressure
coupling conditions, and at 310 K temperature. The Nose-Hoover Langevin piston
algorithm (Phillips et al., 2005) was used to control the target p=1 atm pressure with the Langevin-
PistonPeriod set to 100 fs and LangevinPistonDecay to 50 fs. The first ~25 ns of each trajectory was
discarded based on the convergence of the Ca RMSD.
Each MD trajectory was split into six 32-ns windows overlapping by 28 ns. The S2axis order param-
eters for Ile d1 methyls were calculated from Cg1-Cd1 bond vectors extracted from four of these win-
dows using the trjtool software (Xue et al., 2014; Bremi et al., 1997). The average ±standard
deviation of these order parameters over the four windows is reported for each Ile d1 methyl.
PDB files used in MD simulations and referenced throughout this manuscript (i.e. in Figure 7) can
be accessed at http://www.rcsb.org.
Membrane binding
Ligand binding experiments on membranes containing A2A receptor were carried out based on pre-
viously published protocols (Xu et al., 2011). Pichia cells expressing each construct were used to
generate membranes as follows. Cells were resuspended in lysis buffer (PBS containing 10% glyc-
erol, 2 mM EDTA, and protease inhibitors) and incubated for 2 hr at 37˚C with Zymolyase 20T (AMS
Bio, Abingdon UK) at a final concentration of 50 U/mL. Crude membranes were isolated through
centrifugation at 40,000 rcf for 30 min and dounced in storage buffer (150 mM NaCl, 50 mM HEPES
pH 7.5, 10% glycerol, protease inhibitors). Large cell debris was removed by a low speed spin at
1000 rcf for 10 min, and remaining membranes were subjected to a high speed spin at 140,000 rcf
for 30 min. Pellets were dounced in a minimal volume of storage buffer, flash frozen in LN2, and
stored at  80˚C until needed. Saturation binding was carried out by incubating 1.5–2 mg of mem-
branes with different concentrations of [3H]-ZM241385 (50 Ci/mmol, American Radiolabeled Chemi-
cals, Inc., St. Louis MO) between 0.019 and 10 nM in assay buffer (50 mM Tris pH 7.4, 10 mM
MgCl2, 1 mM EDTA, with 150 mM NaCl or 150 mM KCl as needed) containing 0.1% protease-free
BSA in a final volume of 250 mL per tube. Reactions were incubated at room temperature for 1 hr.
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Non-specific binding was determined using reactions containing 10 mM theophylline. Reactions
were separated on a vacuum manifold using GF/C filters (pre-soaked in assay +0.5% PEI) to retain
membranes and discard unbound ligand. After washing four times with cold assay buffer, bound
radioactivity was quantified using a scintillation counter. For competition binding experiments, ali-
quots of membranes were incubated with 0.5 nM [3H]-ZM241385, and varying concentrations of
cold NECA, from 0.5 nM to 300 mM, were included in the binding reactions. All binding experiments
were carried out as three independent experiments, each performed in duplicate. Data analysis and
fitting was performed with GraphPad Prism (GraphPad Software Inc.).
Reconstitution and GTPgS binding
9 mg of Gs trimer was added to a tube and preincubated on ice for 15 min with 75 mL of 1650 mM
SAPE (1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine; Avanti Lipids), 980 mM porcine
brain phosphatidylserine (Avanti Lipids), 180 mM cholesteryl hemisuccinate (Steraloids) in 20 mM
Hepes pH 8.0, 100 mM NaCl, 0.4% deoxycholate, 0.04% sodium cholate. 35 pmol of A2A receptor
and HMEN buffer (20 mM HEPES pH 8.0, 100 mM NaCl, 3 mM MgCl2, 1 mM EDTA) was added to
the tube for a total volume of 150 mL. The sample was incubated an additional 5 min and applied to
an Ultrogel AcA34 column (Sigma-Aldrich) equilibrated in HMEN buffer. BSA was added to fractions
at a concentration of 0.1 mg/mL and vesicles were flash-frozen for storage at  80˚C. Receptor
recovery was monitored by total ZM241385 binding and ~1 mL after void volume was used in GTPgS
binding assays. Recovery of receptor in this pool was ~13%.
5 mL of vesicles was assayed in a total of 50 mL with 20 mM HEPES pH 8.0, 100 mM NaCl, 2 mM
MgCl2, 1 mM EDTA, 1 mM DTT, 0.1 mg/mL BSA, 100 nM GTPgS with
35S GTPgS as a tracer in either
no ligand, 10 mM NECA agonist, or 100 nM ZM241385 antagonist. Samples were incubated at 30˚C
for 10 min and stopped with 50 mL of quench buffer (20 mM Tris pH 8, 100 mM NaCl, 10 mM
MgCl2, 0.1 mM DTT, 1 mM GTP, and 0.1% Lubrol) and incubated on ice for 10 min. Samples were fil-
tered over BA85 nitrocellulose and filters counted on a liquid scintillation counter after washing 4x
with 20 mM Tris pH 8.0, 100 mM NaCl, 10 mM MgCl2.
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